| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. | Ann Intern Med | 2009 | 4.11 |
| 2 | Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. | Am J Gastroenterol | 2006 | 2.21 |
| 3 | Pharmacokinetics of esomeprazole following varying intravenous administration rates. | Basic Clin Pharmacol Toxicol | 2005 | 0.79 |
| 4 | Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies. | Eur J Gastroenterol Hepatol | 2005 | 0.78 |
| 5 | Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding. | Adv Ther | 2010 | 0.75 |
| 6 | Intravenous Esomeprazole 40mg is Effective for the Control of Intragastric Acid Levels Whether Given as a 3-Minute Injection or a 30-Minute Infusion. | Clin Drug Investig | 2005 | 0.75 |